カテゴリ： MarketLine, アメリカ, 企業調査

SIRVA Inc：企業の戦略・SWOT・財務情報

◆英語タイトル：SIRVA Inc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6013
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：41
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

SIRVA Inc – Strategy, SWOT and Corporate Finance Report
Summary

SIRVA Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

SIRVA, Inc. (SIRVA or ‘the company’) is a privately held company that provides end-to-end relocation and moving services for multi-national corporations, government institutions and consumers. The company also offers mobility services, destination services, title and closing services, household goods moving, temporary accommodations, mortgage services and visa and immigration services. The major brands of the company include SIRVA, North American, Allied, Allied Pickfords and SMARTBOX. The company operates in the Americas, EMEA and Asia Pacific. SIRVA is headquartered in Oakbrook Terrace, Illinois, the US.

Scope

- Detailed information on SIRVA Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting SIRVA Inc in the form of a SWOT analysis
- An in-depth view of the business model of SIRVA Inc including a breakdown and examination of key business segments
- Intelligence on SIRVA Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about SIRVA Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of SIRVA Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess SIRVA Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on SIRVA Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
SIRVA Inc: Company Overview 9
SIRVA Inc: Overview and Key Facts 9
SIRVA Inc: Overview 9
SIRVA Inc: Key Facts 9
SIRVA Inc: Key Employees 10
SIRVA Inc: Key Employee Biographies 11
SIRVA Inc: Major Products and Services 13
SIRVA Inc: Company History 14
SIRVA Inc: Locations and Subsidiaries 18
SIRVA Inc: Key Competitors 20
SIRVA Inc: Company Analysis 21
SIRVA Inc: Business Description 21
SIRVA Inc: SWOT Analysis 22
SIRVA Inc: SWOT Overview 22
SIRVA Inc: Strengths 22
SIRVA Inc: Weaknesses 23
SIRVA Inc: Opportunities 23
SIRVA Inc: Threats 24
SIRVA Inc: Corporate Financial Deals Activity 25
SIRVA Inc: Financial Deals Overview 25
SIRVA Inc: Targets and Partners 27
SIRVA Inc: Top Deals 2014 – 2018YTD* 28
SIRVA Inc: Advisors 29
SIRVA Inc: Top Legal Advisors 29
SIRVA Inc: Top Financial Advisors 29
SIRVA Inc: Mergers and Acquisitions 30
SIRVA Inc: Capital Raising 31
SIRVA Inc: Divestments 32
SIRVA Inc: Private Equity and Ownership 33
SIRVA Inc: Recent Developments 34
SIRVA Inc: News and Events Summary 34
SIRVA Inc: Business Expansion 35
SIRVA Inc: Corporate Governance 36
SIRVA Inc: Financial Deals 36
SIRVA Inc: Strategy and Operations 37
Appendix 39
Contact Us 39
Methodology 39
About MarketLine 40

List of Tables
Table 1: SIRVA Inc: Key Facts
Table 2: SIRVA Inc: Key Employees
Table 3: SIRVA Inc: Company History
Table 4: SIRVA Inc: Locations and Subsidiaries
Table 5: SIRVA Inc: Key Competitors
Table 6: SIRVA Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: SIRVA Inc: M&A Activity by Geography (TTM*)
Table 8: SIRVA Inc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: SIRVA Inc: Targets and Partners
Table 10: SIRVA Inc: Top Deals 2014 - 2018YTD*
Table 11: SIRVA Inc: Legal Advisor Ranking by Value (US$m)
Table 12: SIRVA Inc: Financial Advisor Ranking by Value (US$m)
Table 13: SIRVA Inc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: SIRVA Inc: M&A Activity by Geography (2014 - YTD*2018)
Table 15: SIRVA Inc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 16: SIRVA Inc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 17: SIRVA Inc: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 18: SIRVA Inc: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 19: SIRVA Inc: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 20: SIRVA Inc: News and Events Summary
Table 21: SIRVA Inc: Business Expansion
Table 22: SIRVA Inc: Corporate Governance
Table 23: SIRVA Inc: Financial Deals
Table 24: SIRVA Inc: Strategy and Operations

List of Figures
Figure 1: SIRVA Inc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: SIRVA Inc: M&A Activity by Geography (TTM*)
Figure 3: SIRVA Inc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: SIRVA Inc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: SIRVA Inc: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: SIRVA Inc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: SIRVA Inc: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: SIRVA Inc: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 9: SIRVA Inc: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 10: SIRVA Inc: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[SIRVA Inc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Flex Ltd (FLEX)：企業の財務・戦略的SWOT分析
    Flex Ltd (FLEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Ricoh Company, Ltd. (7752)：企業の財務・戦略的SWOT分析
    Ricoh Company, Ltd. (7752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Aileron Therapeutics Inc (ALRN)-製薬・医療分野：企業M&A・提携分析
    Summary Aileron Therapeutics Inc (Aileron) is a biopharmaceutical company that develops and commercializes novel class of therapeutics. The company provides products such as stapled peptide drugs. Its stapled peptides penetrate cells throughout the body and modulate intracellular protein-protein int …
  • National Institutes of Health：企業のM&A・事業提携・投資動向
    National Institutes of Health - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Institutes of Health Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Petoro AS：企業の戦略的SWOT分析
    Petoro AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Barkers (Northallerton) Limited：企業の戦略的SWOT分析
    Barkers (Northallerton) Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • 23andMe Inc-製薬・医療分野：企業M&A・提携分析
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization …
  • Versalis SpA：企業の戦略的SWOT分析
    Versalis SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Petra Energy Bhd (PENERGY)：石油・ガス：M&Aディール及び事業提携情報
    Summary Petra Energy Bhd (Petra Energy) is an integrated brown field service provider for the upstream oil and gas industry. The company offers services such as designing, procurement, engineering, installation, fabrication, commissioning, maintenance, construction and project management. It also pr …
  • Fujirebio Diagnostics Inc：企業の製品パイプライン分析2018
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent con …
  • PT PLN (Persero)-エネルギー分野：企業M&A・提携分析
    Summary PT PLN (Persero) (PLN) is a state-owned power company that generates, transmits and distributes electricity. It generates power from various sources including coal, natural gas and oil fuel based steam power plants. The company also offers electricity support services such as electricity con …
  • Pulmatrix Inc (PULM)：企業の財務・戦略的SWOT分析
    Summary Pulmatrix Inc (Pulmatrix), formerly Ruthigen Inc is a clinical stage biopharmaceutical company that discovers and develops inhaled therapeutic products intended for prevention and treatment of respiratory diseases and infections. The company develops its pipeline products using its proprieta …
  • MabVax Therapeutics Inc-製薬・医療分野：企業M&A・提携分析
    Summary MabVax Therapeutics Inc (MabVax Therapeutics), a subsidiary of MabVax Therapeutics Holdings Inc is a biopharmaceutical company that develops and commercializes anti-cancer immunotherapies from antibody and vaccine technology. The company offers immune-oncology technology platforms such as hu …
  • Covestro AG (1COV)：企業の財務・戦略的SWOT分析
    Covestro AG (1COV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Aptevo Therapeutics Inc (APVO)：企業の財務・戦略的SWOT分析
    Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Klaria Pharma Holding AB (KLAR)：製薬・医療：M&Aディール及び事業提携情報
    Summary Klaria Pharma Holding AB (Klaria Pharma) is a developer of fast acting medicinal products that designes, develops and commercializ therapeutics for migraine and cancer related pain. The company’s patented drug delivery platform is an alginate-based polymer film, facilitates quick and dependa …
  • Thetis Pharmaceuticals LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary Thetis Pharmaceuticals LLC (Thetis Pharma) is a drug manufacturing company that offers novel immuno-resolving therapies. The company develops and manufactures drugs for type two diabetes and chronic conditions. Its pipeline products include TP252, TP6211, TP113, and TP 101. Thetis Pharma’s T …
  • Galliford Try Plc (GFRD)：企業の財務・戦略的SWOT分析
    Galliford Try Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Orbit International Corp.：戦略・SWOT・企業財務分析
    Orbit International Corp. - Strategy, SWOT and Corporate Finance Report Summary Orbit International Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • CVRx Inc：医療機器：M&Aディール及び事業提携情報
    Summary CVRx Inc (CVRx) is a medical device company that develops and designs implantable device. The company provides barostim neo system, which is designed to trigger the body’s natural blood flow regulation system to treat high blood pressure and heart failure. Its products are used in the treatm …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆